|Mr. Kevin M. King||Pres, CEO & Director||2.13M||21.63M||1956|
|Mr. Matthew C. Garrett||Chief Financial Officer||943.21k||3.55M||1968|
|Mr. Karim Karti||Chief Operating Officer||2.52M||N/A||1969|
|Mr. David A. Vort||Exec. VP of Sales||802.18k||304.38k||1966|
|Mr. Mark J. Day Ph.D.||Exec. VP of R&D||656.12k||5.46M||1971|
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was founded in 2006 and is headquartered in San Francisco, California.
iRhythm Technologies, Inc.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 10; Board: 9; Shareholder Rights: 8; Compensation: 8.